Efficacy of Heterologous Vaccination Using Virus-Like Particles and Vaccinia Virus Containing MIC8 and AMA1 Proteins of <i>Toxoplasma gondii</i>. [PDF]
Kang HJ, Quan FS.
europepmc +1 more source
The effectiveness of COVID-19 Heterologous Vaccination: the experience from a Regional Hospital in Cameroon. [PDF]
Unji PK +6 more
europepmc +1 more source
Characteristics of health care workers with SARS-CoV-2 at a COVID-19 hospital in Türkiye: Homologous versus heterologous vaccination. [PDF]
Alıravcı ID +3 more
europepmc +1 more source
Evaluation of the Humoral Immune Response of a Heterologous Vaccination between BBIBP-CorV and BNT162b2 with a Temporal Separation of 7 Months, in Peruvian Healthcare Workers with and without a History of SARS-CoV-2 Infection. [PDF]
Hueda-Zavaleta M +10 more
europepmc +1 more source
Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice. [PDF]
Frische A +3 more
europepmc +1 more source
Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection. [PDF]
Hwang HS +6 more
europepmc +1 more source
Comparative immunogenicity and neutralizing antibody responses post heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) in HIV-infected patients with varying CD4+ T lymphocyte counts. [PDF]
Chittrakarn S +7 more
europepmc +1 more source
Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao. [PDF]
Ng HM +10 more
europepmc +1 more source

